MEGALIA

Medicinal product

(Invented) name

MEGALIA

Active substance (s)

Megestrolio acetatas

Strength

40 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AB01, Megestrol

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-12-04

Date of renewal

Documents

3046_MEGALIA 40mg-ml_ger_susp_PZ_2025-12-04.docx

3046_MEGALIA 40mg-ml_ger_susp_PL_2025-12-04.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml suspensijos yra:	1 ml
Megestrolio acetatas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119388	105493	1105493	buteliukas	240 ml ir matavimo taurelė N1		Receptinis	LT/L/25/3046/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-12-04	Registruotas